<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS OF ADVANCED
VIRAL RESEARCH CORP. FOR THE SIX MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>


                                                                  
<PERIOD-TYPE>                                     6-MOS
<FISCAL-YEAR-END>                                                    DEC-31-1998
<PERIOD-START>                                                        JAN-1-1999
<PERIOD-END>                                                         JUN-30-1999
<CASH>                                                                    95,618
<SECURITIES>                                                                   0
<RECEIVABLES>                                                                  0
<ALLOWANCES>                                                                   0
<INVENTORY>                                                               19,729
<CURRENT-ASSETS>                                                         160,953
<PP&E>                                                                 1,090,339
<DEPRECIATION>                                                                 0
<TOTAL-ASSETS>                                                         1,747,862
<CURRENT-LIABILITIES>                                                    545,790
<BONDS>                                                                        0
<PREFERRED-MANDATORY>                                                          0
<PREFERRED>                                                                    0
<COMMON>                                                                   3,013
<OTHER-SE>                                                                     0
<TOTAL-LIABILITY-AND-EQUITY>                                           1,747,862
<SALES>                                                                    4,590
<TOTAL-REVENUES>                                                          26,079
<CGS>                                                                          0
<TOTAL-COSTS>                                                                  0
<OTHER-EXPENSES>                                                       1,800,368
<LOSS-PROVISION>                                                               0
<INTEREST-EXPENSE>                                                       311,543
<INCOME-PRETAX>                                                      (2,085,832)
<INCOME-TAX>                                                                   0
<INCOME-CONTINUING>                                                            0
<DISCONTINUED>                                                                 0
<EXTRAORDINARY>                                                                0
<CHANGES>                                                                      0
<NET-INCOME>                                                         (2,085,832)
<EPS-BASIC>                                                             (0.01)
<EPS-DILUTED>                                                             (0.01)